ƒAƒgƒs[«”畆‰Š ‹ãB‘åŠwˆãŠw•””畆‰ÈŠw‹³ŽºTOP‚Ö
‡•¹Ç
ƒAƒgƒs[«”畆‰Š‚ƃEƒBƒ‹ƒXŠ´õÇ ƒAƒgƒs[«”畆‰Š‚ƍ׋ۊ´õÇ ƒAƒgƒs[«”畆‰Š‚Æ”’“àá ƒAƒgƒs[«”畆‰Š‚Ɛ^‹ÛŠ´õÇ
Œ¤‹†‘ã•\ŽÒ@ŒÃ]‘—²
Œ¤‹†‹¦—͎ҁ@‹g‘º‰f—¢A’|“à‘A]ú±mˆê
‹ãB‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰@”畆‰ÈŠwuÀ
‹ãB‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰@”畆‰ÈŠwuÀ
ƒAƒgƒs[«”畆‰Š‚Ɛ^‹ÛŠ´õÇ
—vŽ| ‚Í‚¶‚ß‚É Œ¤‹†–Ú“I •û–@ Œ‹‰Ê‚ƍlŽ@ Œ‹˜_ ŽQl•¶Œ£
‡•¹Ç•]‰¿•\ˆê——
•]‰¿•\‚ÌŒ©•û
•]‰¿–@‚ÌŒ©•û
ŽQl•¶Œ£
1. Savolainen J. et al., M.Candida albicans and atopic dermatitis. Clin Exp Allergy ;23:332-9, 1993
2. Patrizi A. et al, Clinical evaluation of the efficacy and tolerability of the gNoAll Bimbi Pasta Trattantehbarrier cream in napkin dermatitis. Minerva Pediatr;59(1):23-8, 2007]
3. Johansson C. et al, Atopy patch test reaction to Malassezia allergens differentiate subgroups of atopic dermatitis patients. Br J dermatol;148(3):479-88, 2003
4. óŒÃ‰ÀŽq‚çACandida albicans, Malassezia furfur‚̐¸»RŒ´‚ɑ΂·‚éƒAƒgƒs[«”畆‰ŠŠ³ŽÒ‚Ì”½‰ž«‚ɑ΂·‚錟“¢. ƒAƒŒƒ‹ƒM[;51(8):615-21, 2002
5. Sugita T. et al, ƒAƒgƒs[«”畆‰ŠŠ³ŽÒ”畆‚É’è’…‚·‚é’SŽq‹ÛŒny•êCryptococcus diffluens‹y‚ÑC.liquefaciens. Microbiology and Lmmunology;47(12):945-50, 2003
6. Kato Hiroshi et al, y‘f–Ɖu‘ª’è–@‚ð—p‚¢‚½ƒAƒgƒs[«”畆‰ŠŠ³ŽÒ‚Ì8Ží‚ÌŒŒ´’†ƒ}ƒ‰ƒZƒWƒA‹Û‚ɑ΂·‚é“ÁˆÙ“IIgER‘Ì‚ÌŒŸo‚Æ’è—ʉ». Microbiology and Lmmunology;50(11):851-56, 2006
7. Sugita T. et al, ƒAƒgƒs[«”畆‰Š‚¨‚æ‚ÑŒ’íl”畆‚É’è’…‚·‚éMalassezia retricta‚̈â“`Žq‘½Œ^. Microbiology and Lmmunology;48(10):755-59, 2004
8. ¬—яƎq‚çAƒAƒgƒs[«”畆‰Š‚É‚¨‚¯‚é^‹ÛƒAƒŒƒ‹ƒM[‚ƍR^‹Û—Ö@‚ÌŒø‰Ê‚ɂ‚¢‚Ä‚ÌŒŸ“¢@‘¦ŽžŒ^”½‰žA’x‰„Œ^”½‰ž‚ðŠÜ‚ß‚Ä. ƒAƒŒƒ‹ƒM[;55(2):126-33, 2006
9. Mayser P. et al,@Treatment of head and neck dermatitis with ciclopiroxolamine cream?results of a double-blind, placebo-controlled study. Skin Pharmacol Physiol ;19:153-158, 2006
10. Wong AW. et al, Is topical antimycotic treatment useful as ajuvant therapy for flexural atopic dermatitis: randomized, double-blind, controlled trial using one side of the elbow or knee as a control. Int J Dermatol;47(2):187-91, 2008
11. Takechi M. Minimum effective dosage in the treatment of chronic atopic dermatitis with itraconazole. J Int Med Res.;33(3):273-83, 2005
12. Svejgaard EL. et al, Treatment of head and neck dermatitis comparing itraconazole 200 mg and 400 mg daily for 1 week with placebo. J Eur Acad Dermatol Venereol;18(4):445-9, 2004
13. “c“ˆ@–›”üAMalassezia‚ÆŽ‰˜R«”畆‰ŠEƒAƒgƒs[«”畆‰Š. ^‹ÛŽ;46:163-7, 2005
ƒgƒbƒvƒy[ƒW‚Ö–ß‚é ã‚Ö–ß‚é
‹ãB‘åŠwˆãŠw•””畆‰ÈŠw‹³ŽºTOP‚Ö